• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Williams Syndrome Linked to Substantially Higher Risks of Refractive Errors and Cataracts

by
November 16, 2026
in Health
Reading Time: 6 mins read
0
Williams Syndrome Linked to Substantially Higher Risks of Refractive Errors and Cataracts

Williams Syndrome Linked to Substantially Higher Risks of Refractive Errors and Cataracts

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A large-scale retrospective observational cohort study analyzing electronic health record data across the United States has revealed that individuals diagnosed with Williams syndrome experience significantly elevated risks of several major ophthalmic manifestations compared to age- and sex-matched controls. Published in Frontiers in Ophthalmology by a research team from Drexel University College of Medicine and the Wilmer Eye Institute at Johns Hopkins University School of Medicine, the real-world investigation demonstrated that coded refractive errors represent the most frequent and consistently elevated ocular diagnoses among patients with this rare condition. Specifically, individuals with Williams syndrome exhibited more than five times the risk of hypermetropia and more than three times the risk of astigmatism relative to control subjects drawn from the same multi-institutional clinical network. The investigation also identified statistically significant increases in the risks of myopia and cataract formation. By examining coded clinical encounters captured across participating healthcare organizations, the researchers quantified outcome frequencies and comparative risk estimates at a population scale, addressing longstanding evidence gaps in pediatric ophthalmology and medical genetics.

Williams syndrome is a rare neurodevelopmental disorder caused by a contiguous gene microdeletion on chromosome 7q11.23, with an estimated live birth incidence ranging between 1 in 7,500 and 1 in 20,000. Clinically, the disorder is recognized by a distinctive cognitive and behavioral profile, cardiovascular anomalies, connective tissue abnormalities, and characteristic facial features. Beyond these well-documented systemic features, visual and ocular manifestations represent an important but historically understudied clinical burden in affected individuals. Earlier clinical publications and smaller case series have noted a broad spectrum of potential ocular anomalies, including strabismus, amblyopia, stellate iris patterns, and refractive errors. Scattered case reports have also linked Williams syndrome to rarer conditions such as keratoconus, megalocornea, rod-cone retinal dystrophy, optic nerve hypoplasia, congenital anterior segment dysgenesis, cataract, and Peters anomaly. Visual disorders can critically impair developmental milestones and overall quality of life, which has prompted professional bodies such as the American Academy of Pediatrics to recommend ophthalmologic screening for children diagnosed with the condition.

Despite longstanding clinical recognition of these associations, existing literature on ophthalmic manifestations in Williams syndrome has been predominantly restricted to small institutional cohorts, specialty clinic samples, or isolated case reports that frequently enrolled fewer than one hundred individuals. These earlier investigations often evaluated constrained age intervals, focused almost exclusively on younger pediatric groups, and concentrated disproportionately on hyperopia and esotropia without evaluating less common strabismus subtypes or the full spectrum of refractive disorders. Furthermore, earlier studies were generally unable to provide nationwide comparative estimates against matched control populations, leaving the relative magnitude of ocular risks largely undefined. The rarity of the syndrome has historically impeded single centers from accumulating sufficiently powered samples to evaluate both common and infrequent ocular manifestations simultaneously. To overcome these constraints, the study authors utilized aggregated electronic health record data to conduct an expansive, nationwide assessment of coded ophthalmic outcomes in affected individuals compared with matched individuals undergoing general health evaluations.

The investigation utilized clinical data derived from the TriNetX United States Network, a collaborative platform comprising de-identified, aggregated electronic health records from participating healthcare organizations nationwide. The comparative analyses were executed using the platform’s analytical architecture, with final comparative workflows updated on October 13, 2026. Williams syndrome patients were identified using the International Classification of Diseases, Tenth Revision, Clinical Modification code Q93.82, which originally took clinical effect on October 1, 2018; accordingly, all index diagnoses for the syndrome cohort occurred on or after that calendar date. Demographic metrics captured at index included age, sex, race, and ethnicity. A total of 1,232 individuals met the initial query parameters for the Williams syndrome cohort. For comparison, control subjects were selected from the same clinical network and were required to have no recorded diagnosis of Williams syndrome while meeting an identical general medical examination criterion established by diagnostic code Z00, ensuring a shared healthcare engagement baseline.

To mitigate baseline confounding while preserving adequate sample size within a rare disease population, investigators performed one-to-one propensity score matching on index age and sex utilizing the platform’s multivariable logistic regression algorithm with greedy nearest-neighbor matching and a caliper of 0.1 standard deviations. Prior to matching, the Williams syndrome cohort demonstrated a mean age at index of 19.1 years with a standard deviation of 18.4 years, while the unmatched control pool had a mean age of 35.7 years with a standard deviation of 25.1 years. Following propensity matching, the final analytic sample comprised 1,198 individuals with Williams syndrome matched to 1,198 controls, achieving complete balance for index age with a mean of 19.1 years, a median of 14 years, and an interquartile range of 26 years in both groups. Sex was equally balanced, with 598 females representing 49.9 percent and 597 males representing 49.8 percent of each cohort. Among matched Williams syndrome subjects, racial and ethnic documentation identified 807 White individuals, 158 Black or African American individuals, 35 Asian individuals, and 203 Hispanic or Latino individuals, while documented baseline eye examination codes were recorded in 22 patients.

Descriptive and comparative analyses of post-index ophthalmic outcomes demonstrated that refractive errors were the most prevalent estimable diagnoses among individuals with Williams syndrome. Astigmatism occurred in 125 out of 1,137 evaluable patients with Williams syndrome, representing a prevalence of 11.0 percent, compared with 37 out of 1,187 matched controls, or 3.1 percent. This yielded an absolute risk difference of 7.88 percentage points and a risk ratio of 3.53 with a 95 percent confidence interval of 2.47 to 5.04. Hypermetropia was diagnosed in 115 out of 1,146 evaluable subjects with Williams syndrome, corresponding to 10.0 percent, compared with 21 out of 1,193 controls, or 1.8 percent, representing an absolute risk difference of 8.27 percentage points and a risk ratio of 5.70 with a 95 percent confidence interval of 3.61 to 9.01. Myopia was documented in 58 out of 1,161 evaluable patients with Williams syndrome, or 5.0 percent, compared to 32 out of 1,186 control subjects, or 2.7 percent, yielding a risk ratio of 1.85 with a 95 percent confidence interval of 1.21 to 2.83. All three refractive error risk elevations remained statistically significant after adjusting for multiplicity via the Benjamini-Hochberg false discovery rate procedure.

Beyond refractive errors, the study evaluated structural ocular diseases, lens pathologies, and strabismus subtypes. Cataract was diagnosed in 31 out of 1,169 evaluable individuals with Williams syndrome, representing 2.7 percent, compared with 13 out of 1,189 matched controls, or 1.1 percent, reflecting a significant risk ratio of 2.43 with a 95 percent confidence interval of 1.28 to 4.61 that retained statistical significance following false discovery rate correction. Hypertropia, a vertical strabismus subtype, was documented in 11 out of 1,193 subjects with Williams syndrome, representing an event frequency of 0.92 percent, whereas zero cases were observed among the 1,198 matched controls; because of the zero-event denominator in the control cohort, the risk ratio could not be mathematically estimated, although the nominal comparison remained significant. Longitudinal time-to-event evaluations using Kaplan-Meier analyses showed sustained risk increases for astigmatism, with a hazard ratio of 2.86 and a 95 percent confidence interval of 1.98 to 4.13, and for hypermetropia, with a hazard ratio of 4.65 and a 95 percent confidence interval of 2.92 to 7.41. Conversely, the hazard ratios for myopia at 1.43 and cataract at 1.90 included 1 within their 95 percent confidence intervals in proportional hazards modeling.

The study also systematically tracked rare ocular manifestations previously described in clinical literature, though many could not be precisely quantified due to network data governance rules. Congenital anterior segment dysgenesis recorded zero post-index events across both the 1,198 Williams syndrome subjects and the 1,197 evaluable controls. Several other recognized ocular conditions, including amblyopia, esotropia, exotropia, degenerative myopia, keratoconus, megalocornea, optic nerve hypoplasia, rod-cone dystrophy, and Peters anomaly, were suppressed under TriNetX small-cell privacy policies, which restrict reporting when event counts are ten or fewer individuals. Consequently, exact prevalence values, risk differences, and relative risks could not be estimated for these specific diagnoses within the matched cohort. The authors noted that while these privacy constraints safeguard patient confidentiality and prevent individual re-identification in rare disease cohorts, they restrict statistical modeling for uncommon manifestations and prevent granular comparative analyses for conditions that occur at very low baseline frequencies across aggregated healthcare platforms.

When comparing their findings to dedicated single-center ophthalmology cohorts, the investigators observed that the overall frequencies of coded ophthalmic diagnoses in the TriNetX platform were lower than those historically cited in specialized ophthalmic literature. For example, published clinic studies have previously reported strabismus rates exceeding 50 percent and high rates of hyperopia among pediatric cohorts. The authors explained that this observed divergence is unlikely to stem solely from the wider age distribution of the electronic health record population. Instead, lower diagnostic frequencies in multi-institutional real-world data are more likely attributable to clinical under-ascertainment, specialized eye care delivered outside participating healthcare systems, and minor ophthalmic findings managed in routine care without being formally coded as distinct diagnostic entities. A notable demographic feature was that the dataset captured individuals spanning a wide age range from pediatric patients to older adults, with an overall mean cohort age of 19.1 years, providing insight beyond early childhood, although formal age-stratified subgroup analyses were not executed.

The authors outlined important methodological limitations inherent to secondary analyses of real-world electronic health record databases. Because the TriNetX platform relies entirely on de-identified administrative and billing codes, individual medical charts could not be manually reviewed, preventing clinical verification of visual acuity, ophthalmic testing parameters, disease severity, or genetic confirmation of the 7q11.23 deletion. Although the study introduced a general medical examination entry requirement across cohorts to balance clinical exposure, differential healthcare utilization and heightened surveillance among individuals with complex genetic conditions may have inflated diagnostic capture relative to controls, limiting causal conclusions. Furthermore, propensity matching was restricted to age and sex; residual confounding remains possible regarding race, ethnicity, developmental delay, prematurity, total encounter density, and eye examination frequency. Despite these constraints, the study provides valuable population-level benchmarks establishing elevated risks for hypermetropia, astigmatism, myopia, and cataracts, supporting recommendations for routine early vision screening in Williams syndrome.

Subject of Research: Ophthalmic manifestations and comparative risk estimates in Williams syndrome

Article Title: Ophthalmic manifestations of Williams Syndrome: a large scale real-world analysis

Article References: Wang, T. J., Shah, Y., & Berkenstock, M. K. (2026). Ophthalmic manifestations of Williams Syndrome: a large scale real-world analysis. Frontiers in Ophthalmology, 6, 1937794. https://doi.org/10.3389/fopht.2026.1937794

Image Credits: AI Generated

DOI: 10.3389/fopht.2026.1937794

Keywords: Williams syndrome, pediatric ophthalmology, refractive errors, astigmatism, hypermetropia, myopia, cataracts, strabismus, hypertropia, TriNetX network, electronic health records, real-world evidence, propensity score matching, relative risk, ocular manifestations, ophthalmic screening, genetic disorders

News Source: Ophelia Keating. (November 16, 2026). Williams Syndrome Linked to Substantially Higher Risks of Refractive Errors and Cataracts. Scienmag.

Tags: astigmatismcataractselectronic health recordsGenetic disordershypermetropiahypertropiamyopiaocular manifestationsophthalmic screeningpediatric ophthalmologypropensity score matchingReal-world evidencerefractive errorsrelative riskstrabismusTriNetX networkWilliams syndrome
Share12Tweet7Share2ShareShareShare1

Related Posts

Postoperative Inotropic Support and Hypotension Link Pulmonary Hypertension to Kidney Injury

Postoperative Inotropic Support and Hypotension Link Pulmonary Hypertension to Kidney Injury

November 18, 2026
Decentralized Medical Residency Admissions in Israel Cause Systemic Delays and Maldistribution

Decentralized Medical Residency Admissions in Israel Cause Systemic Delays and Maldistribution

November 18, 2026

Swedish Study Examines Mental Health Staff Experiences With Mobile Psychiatric Teams

November 18, 2026

Over Half of Emergency Patients With ICU Limits Survived Resuscitation Unit Care

November 18, 2026

POPULAR NEWS

  • Multi-Environment Trials Identify Four Superior High-Yielding Barley Genotypes in Egypt

    Multi-Environment Trials Identify Four Superior High-Yielding Barley Genotypes in Egypt

    29 shares
    Share 12 Tweet 7
  • Shandong Listeria Study Links Food and Clinical Isolates Using Genomic Profiling

    29 shares
    Share 12 Tweet 7
  • Engineers Develop Curved Lithium-Sulfur Battery Electrodes for Drone Frame Energy Storage

    29 shares
    Share 12 Tweet 7
  • Maternal Serum Elements Link to Cardiometabolic Risk Factors in Pregnancy

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Postoperative Inotropic Support and Hypotension Link Pulmonary Hypertension to Kidney Injury

Decentralized Medical Residency Admissions in Israel Cause Systemic Delays and Maldistribution

Swedish Study Examines Mental Health Staff Experiences With Mobile Psychiatric Teams

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.